🔎 Trials Near Me

Dachaigh › Leukemia Lymphocytic Cronach › Virginia › Arlington

Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Arlington, VA

Tha 4 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Arlington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

A’ fastadhÌre 3
  • Inova Schar Cancer Institute ( Site 0015), Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06136559

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

A’ fastadhÌre 2
  • Virginia Cancer Specialists, PC, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221500

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

A’ fastadhÌre 3
  • Virginia Cancer Specialists, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07516093

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A’ fastadhÌre 3
  • Virginia Cancer Specialists - Fairfax /ID# 268155, Fairfax · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT06428019

Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile

Sgrùdaidhean eile ann an Arlington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.